Myeloproliferative disorder-associated massive splenomegaly

Clin Adv Hematol Oncol. 2008 Apr;6(4):278, 281-2.
No abstract available

Publication types

  • Review

MeSH terms

  • Cell Differentiation / drug effects*
  • Hematopoiesis / drug effects
  • Humans
  • Hydroxyurea / therapeutic use
  • Myeloproliferative Disorders / complications*
  • Protein Kinase Inhibitors / therapeutic use
  • Radiotherapy, Adjuvant
  • Splenectomy
  • Splenomegaly / etiology
  • Splenomegaly / therapy*

Substances

  • Protein Kinase Inhibitors
  • Hydroxyurea